The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in rat-1 fibroblasts

Metabolism: Clinical and Experimental

Volumn 45, Issue 12, 1996, Pages 1474-1482

  Takata, Yasumitsu ^a   Imamura, Takeshi ^a   Haruta, Tetsuro ^a   Sasaoka, Toshiyasu ^a   Morioka, Hisao ^a   Ishihara, Hajime ^a   Sawa, Tasuku ^a   Usui, Isao ^a   Ishiki, Manabu ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; GLYCOGEN SYNTHESIS; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 12644252003     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90175-4     Document Type: Article

References (46)

1. Froesch ER, Schmid C, Schwander J, et al: Actions of insulin-like growth factors. Annu Rev Physiol 47:443-467, 1985
2. Ebina Y, Ellisu L, Jarnagin K, et al: The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signaling. Cell 40:747-758, 1985
3. Ullich A, Gray A, Tam AW, et al: Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512, 1986
4. Ullrich A, Schlessinger J: Signal transduction by the receptors with tyrosine kinase activity. Cell 61:203-212, 1990
5. Obberghen EV: Signaling through the insulin receptor and the insulin-like growth factor-I receptor. Diabetologia 37:S125-S134, 1994 (suppl 2)
6. Giorgetti S, Pelicci PG, Pelicci G, et al: Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur J Biochem 223:195-202, 1994
7. Beguinot F, Smith RJ, Kahn CR, et al: Phosphorylation of insulin-like growth factor I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells. Biochemistry 27:3222-3228, 1988
8. Tartare S, Ballotti R, Obberghen EV: Interaction between heterologous receptor tyrosine kinases. Hormone-stimulated insulin receptors activate unoccupied IGF-I receptors. FEBS Lett 295:219-222, 1991
9. Kuzuya H, Matsuura N, Sakamoto M, et al: Trial of insulin like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42:696-705, 1993
10. Turkalj I, Keller U, Ninnis R, et al: Effect of increasing doses of recombinant human insulin-like growth factor I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75:1186-1197, 1992
11. Dohm GL, Elton CW, Raji MS, et al: IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes 39:1028-1032, 1990
12. Dills DG, Moss SE, Klein R, et al: Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 40:1725-1730, 1991
13. Haruta T, Takata Y, Iwanishi M, et al: Ala 1048-Asp mutation in the kinase domain of insulin receptor causes defective kinase activity and insulin resistance. Diabetes 42:1837-1844, 1993
14. Kaplowits PB, D'ercole AJ: Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C. J Clin Endocrinol Metab 55:741-748, 1982
15. Craig JW, Larner J, Locker EF, et al: Mechanism of insulin resistance in cultured fibroblasts from a patient with leprechaunism: Impaired post-binding actions of insulin and multiplication-stimulating activity. Metabolism 33:1084-1096, 1984
16. Levy-Toledano R, Caro LH, Accili D, et al: Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J 13:835-842, 1994
17. Takata Y, Kobayashi M: Insulin-like growth factor I signaling through heterodimers of insulin and insulin-like growth factor I receptors. Diabete Metab 20:31-36, 1994
18. Takata Y, Webster NJ, Olefsky JM: Mutation of the carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. J Biol Chem 266:9135-9139, 1991
19. Takata Y, Webster NJ, Olefsky JM: Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites. J Biol Chem 267:9065-9070, 1992
20. Langloins WJ, Sasaoka T, Yip CC, et al: Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor I or insulin receptors. Endocrinology 136:1978-1986, 1995
21. Sasaoka T, Draznin B, Leitner JW, et al: She is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem 269:10734-10738, 1994
22. Prager D, Yamasaki H, Weber MM, et al: Human insulin-like growth factor I receptor function in pituitary cells in suppressed by a dominant negative mutant. J Clin Invest 90:2117-2122, 1992
23. Gronborg M, Wulff BS, Rasmussen JS, et al: Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J Biol Chem 268:23435-23440, 1993
24. Li S, Ferber A, Miura M, et al: Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem 269:32558-32564, 1994
25. Ueno H, Corbert H, Escobedo JA, et al: Inhibition of PDGF β receptor signal transduction by coexpression of a truncated receptor. Science 252:844-848, 1991
26. Steele-Pwekins G, Turner J, Edman JC, et al: Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263:11486-11492, 1988
27. Hofmann C, Goldfine ID, Whittaker J: The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem 264:8606-8611, 1989
28. Moxham CP, Duronio V, Jacobs S: Insulin-like growth factor I receptor β-subunit heterogeneity. J Biol Chem 264:13238-13244, 1989
29. Chin JE, Tabaré JM, Ellis L, et al: Evidence for hybrid rodent and human insulin receptors in transfected cells. J Biol Chem 266:15587-15590, 1991
30. Soos MA, Field CE, Siddle K: Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290:419-426, 1993
31. Treadway JL, Morrison BD, Soos MA, et al: Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA 88:214-218, 1991
32. Frattali AL, Treadway JL, Pessin JE: Transmembrane signaling by the human insulin receptor kinase. J Biol Chem 267:19521-19528, 1992
33. Sasaoka T, Rose DW, Jhun BH, et al: Evidence for a functional role of She protein in mitogenic signaling induced by insulin, insulin-like growth factor-I and epidermal growth factor. J Biol Chem 269:13689-13694, 1994
34. McClain DA, Maegawa H, Thies SR, et al: Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors. J Biol Chem 265:1678-1682, 1990
35. Kahn CR, White MF, Shoelson SE, et al: The insulin receptor and its substrate: Molecular determinants of early events in insulin action. Recent Prog Horm Res 48:291-339, 1993
36. Hubbard SR, Wei L, Ellis L, et al: Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-754, 1994
37. Sasaoka T, Langlois WJ, Rose DW, et al: Mechanism of enhanced transmembrane signaling by an insulin receptor lacking a cytoplasmic β-subunit domain. J Biol Chem 270:10885-10892, 1995
38. Yamamoto-Honda R, Kadowaki T, Momonura K, et al: Normal insulin substrate-I phosphorylation in autophosphorylation-defective truncated insulin receptor. J Biol Chem 268:16859-16865, 1993
39. Alberti KGMM, Krall LP (eds): The Diabetes Annual, vol 3. Amsterdam, The Netherlands, Elsevier Science, 1987, pp 433-488
40. Kublaoui B, Lee J, Pilch PE: Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J Biol Chem 270:59-65, 1995
41. Lazor DF, Wiese RJ, Brady MJ, et al: Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 270:20801-20807, 1995
42. Segar R, Biener Y, Feinstein R, et al: Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-1-acetate (TPA) and insulin. J Biol Chem 270:28235-28330, 1995
43. Taouis M, Levy-Toledano R, Caro LHP, et al: Rescue and activation of a binding-deficient insulin receptor. J Biol Chem 269:27762-27766, 1994
44. Taouis M, Levy-Toledano R, Roach P, et al: Structural basis by which a recessive mutation in the alpha-subunit of the insulin receptor affects insulin binding. J Biol Chem 269:14192-14198, 1994
45. Seely BL, Reichart DR, Takata Y, et al: A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology 136:1635-1641, 1995
46. Chang PY, Goodyear LJ, Benecke H, et al: Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors. J Biol Chem 270:12593-12600, 1995